Greetings from Accenture Services Ltd !
About US : Accenture is a global management consulting, technology services and outsourcing company, with 257,000 people serving clients in more than 120 countries. Combining unparalleled experience, comprehensive capabilities across all industries and business functions, and extensive research on the worlds most successful companies, Its home page is www.accenture.com.
Educational qualification: B.Pharam/Mpharm/ BDS.
Experience: 2 yr + relevant Exp in Regulatory Affairs .
Designation: Reg Ops Associate RO
Eligibility: Anywhere in India, willing to relocate to Bangalore
Required:
Relevant & Overall experience: 2 in regulatory affairs with tool knowledge.
eCTD/ CTD/ NeeS submission compilations
Worked on electronic or paper submissions
NDA, IND, ANDA, MAA, CTA, Amendment Submission, supplemental, Variations, Response to HAs, Follow-up measures, Annual Reports
Countries worked US, EU, ROW, International, Australia, and South Africa.
Labeling, Structured product labeling, labeling Submission; XML backbone Metadata etc.
Publishing Tools worked on :- ISI publisher , ISI toolbox, ISI eCTD Xpress, Insight Publisher, PharmaReady, Educe, DocBridge, Extedo; eCTD Complier/ Publisher; CH SwissMedic eCTD complier etc.
If this is the opportunity you are looking for, then please contact or send your updated resume to HR Anitha.
You can email me your updated resume at anitha.augustine@accenture.com or Call -080 39165994.
Thanks & Regards,
Anitha.Augustine | ABS- Recruitment |Accenture, India
anitha.augustine@accenture.com
Accenture
www.careers.accenture.com/India
Accenture is a global management consulting, technology services and outsourcing company, with approximately 261,000 people serving clients in more than 120 countries. Combining unparalleled experience, comprehensive capabilities across all industries and business functions, and extensive research on the world's most successful companies, Accenture collaborates with clients to help them become high-performance businesses and governments. The company generated net revenues of US$27.9 billion for the fiscal year ended Aug. 31, 2012.